Xiaowu Zhang

Xiaowu Zhang is currently the Director of Antibody Discovery at Abpro since September 2022. Before joining Abpro, Xiaowu Zhang held various roles at Cell Signaling Technology (CST) from July 2005 to September 2022, starting as a Scientist and moving up to Principal Scientist and Fellow. Xiaowu Zhang holds a PhD in Biochemistry from Brandeis University, where they completed their education from 1994 to 2000. Prior to that, Xiaowu Zhang earned a BSc in Biochemistry from Peking University.